Key Market Indicators
Luxembourg's antidepressant medicine sales are projected to decline to approximately $3.7 million by 2028, down from around $4.4 million in 2023. This represents an average annual decrease of 2.5%. Since the year 2000, the Luxembourger market for antidepressants has seen a consistent decline, averaging a 5.7% reduction each year. In the latest rankings for 2023, Luxembourg held the 17th position, with Estonia surpassing it with sales totaling $4.4 million. Leading the rankings, Spain, Italy, and Australia secured the second, third, and fourth positions, respectively.
